Liu David Y
Insider CIK 1675881 · PTGX Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2022-11-16 | 2022-11-17 | 5,999 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2022-11-16 | 2022-11-17 | 35,656 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2022-11-16 | 2022-11-17 | 35,331 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2022-11-16 | 2022-11-17 | 13,767 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2022-11-16 | 2022-11-17 | 9,726 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2022-11-16 | 2022-11-17 | 13,767 | $0.87 | $12.0K | 80,878 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2022-11-16 | 2022-11-17 | 35,331 | $4.21 | $148.7K | 167,590 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2022-11-16 | 2022-11-17 | 9,726 | $1.89 | $18.4K | 90,604 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2022-11-16 | 2022-11-17 | 5,999 | $1.89 | $11.3K | 96,603 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2022-11-16 | 2022-11-17 | 35,656 | $1.16 | $41.4K | 132,259 | SEC↗ |
| PTGX Protagonist Therapeutics, | F Tax w/h | 2022-02-28 | 2022-03-02 | 2,119 | $24.28 | $51.4K | 66,538 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2022-02-15 | 2022-02-17 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2022-02-15 | 2022-02-17 | 10,000 | — | $0 | 68,657 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2021-08-17 | 2021-08-19 | 10,000 | — | $0 | 13,767 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2021-08-17 | 2021-08-19 | 10,000 | $0.87 | $8.7K | 73,033 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2021-08-17 | 2021-08-19 | 14,779 | $47.56 | $702.9K | 58,254 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2021-02-26 | 2021-02-26 | 65,000 | — | $0 | 65,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2021-02-26 | 2021-02-26 | 10,000 | — | $0 | 62,427 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2020-02-28 | 2020-02-28 | 70,000 | — | $0 | 70,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2019-08-06 | 2019-08-08 | 3,395 | $8.85 | $30.0K | 49,802 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2019-03-01 | 2019-03-04 | 810 | $8.03 | $6.5K | 51,197 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2019-02-28 | 2019-03-04 | 90,000 | — | $0 | 90,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2019-02-28 | 2019-03-04 | 15,000 | — | $0 | 52,007 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2019-02-06 | 2019-02-08 | 3,821 | $7.74 | $29.6K | 37,007 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-08-15 | 2018-08-17 | 17,200 | — | $0 | 17,200 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2018-08-15 | 2018-08-17 | 25,800 | — | $0 | 40,828 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2018-03-12 | 2018-03-13 | 3,500 | — | $0 | 35,331 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2018-03-12 | 2018-03-13 | 3,500 | $4.21 | $14.7K | 18,528 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2018-03-12 | 2018-03-13 | 3,500 | $21.29 | $74.5K | 15,028 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2018-03-02 | 2018-03-02 | 875 | — | $0 | 9,725 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2018-03-02 | 2018-03-02 | 875 | $20.00 | $17.5K | 13,322 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2018-03-02 | 2018-03-02 | 875 | $1.89 | $1.7K | 14,197 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-02-28 | 2018-03-02 | 56,500 | — | $0 | 56,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2018-02-28 | 2018-03-02 | 9,500 | — | $0 | 13,322 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2018-01-16 | 2018-01-17 | 875 | — | $0 | 10,600 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2018-01-16 | 2018-01-17 | 875 | $20.00 | $17.5K | 3,822 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2018-01-16 | 2018-01-17 | 875 | $1.89 | $1.7K | 4,697 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-12-18 | 2017-12-20 | 875 | — | $0 | 11,475 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-12-18 | 2017-12-20 | 875 | $1.89 | $1.7K | 4,697 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-12-18 | 2017-12-20 | 875 | $20.00 | $17.5K | 3,822 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-11-30 | 2017-12-01 | 875 | — | $0 | 12,350 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-11-30 | 2017-12-01 | 875 | $20.00 | $17.5K | 3,822 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2017-11-30 | 2017-12-01 | 875 | $1.89 | $1.7K | 4,697 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-11-13 | 2017-11-15 | 3,500 | — | $0 | 38,831 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-11-13 | 2017-11-15 | 3,500 | — | $0 | 13,225 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-11-13 | 2017-11-15 | 3,500 | $16.97 | $59.4K | 3,822 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-11-13 | 2017-11-15 | 3,500 | $1.89 | $6.6K | 7,322 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-11-13 | 2017-11-15 | 3,500 | $4.21 | $14.7K | 7,322 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-11-13 | 2017-11-15 | 3,500 | $16.97 | $59.4K | 3,822 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-08-28 | 2017-08-29 | 3,500 | — | $0 | 42,331 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-08-28 | 2017-08-29 | 3,500 | $15.00 | $52.5K | 2,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-08-28 | 2017-08-29 | 3,500 | $4.21 | $14.7K | 5,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-07-10 | 2017-07-12 | 3,500 | — | $0 | 16,725 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-07-10 | 2017-07-12 | 3,500 | $1.89 | $6.6K | 5,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-07-10 | 2017-07-12 | 3,500 | $12.68 | $44.4K | 2,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2016-10-11 | 2016-10-13 | 65,000 | — | $0 | 65,000 | SEC↗ |